Bioequivalence studies: Inspectio...
Bioequivalence studies: Inspections and regulators' expectations

Solutions OP Clinical Trials UK by Olga Peycheva

Episode notes

Our latest podcast is dedicated to bioequivalence studies and their specific challenges. We also cover what was discussed in terms of inspection findings, cases studies and expectations by FDA and Health Canada on their recent symposium in June 2026. In addition, Lydia Ainsworth, shares with us her practical experience from site level and monitoring level on common issues with blood sample collections.

Keywords
clinical trialsGCPclinical trials set upGCP inspectionBioequivalence studiespharmacokinetics samples